Back to Search
Start Over
Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
- Source :
-
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society [Liver Transpl] 2022 Jul; Vol. 28 (7), pp. 1224-1230. Date of Electronic Publication: 2022 Apr 21. - Publication Year :
- 2022
-
Abstract
- Patients with portopulmonary hypertension (POPH) have an increased cardiovascular and overall mortality risk when undergoing liver transplantation (LT). However, such risk is not captured in their Model for End-Stage Liver Disease (MELD) laboratory score. POPH MELD exception criteria were established in 2006 with the aim of prioritizing these patients for LT prior to pulmonary hypertension (PH) progression and eventual right heart failure. The original criteria emphasized a posttreatment, pre-LT mean pulmonary arterial pressure (mPAP) of <35 mm Hg and pulmonary vascular resistance (PVR) <400 dynes-s-cm <superscript>-5</superscript> or <5 Wood units (WU). Since 2006, there have been important advances in the treatment of POPH with pulmonary arterial hypertension (PAH)-targeted therapies and newer evidence regarding LT outcomes and risk factors for perioperative mortality. Specifically, PVR rather than mPAP has been shown to be more strongly associated with outcomes, including mortality. In addition, among treated patients with POPH, mPAP may be persistently elevated related to an elevated cardiac output or other factors that do not necessarily reflect POPH disease severity. Thus, in February 2021, the Organ Procurement and Transplantation Network approved proposed modifications to POPH MELD exception criteria, now allowing either of the following posttreatment, pre-LT hemodynamic profiles: mPAP less than 35 mm Hg and posttreatment PVR less than 400 dynes-s-cm <superscript>-5</superscript> (or less than 5 WU) or mPAP greater than or equal to 35 mm Hg and less than 45 mm Hg and posttreatment PVR less than 240 dynes-s-cm <superscript>-5</superscript> (or less than 3 WU). This article reviews the history of the POPH MELD exception criteria, describes the recent modifications to the exception criteria and the evidence supporting them, and highlights unanswered questions and areas for future research.<br /> (© 2022 American Association for the Study of Liver Diseases.)
- Subjects :
- Humans
Severity of Illness Index
End Stage Liver Disease complications
End Stage Liver Disease surgery
Hypertension, Portal diagnosis
Hypertension, Portal etiology
Hypertension, Portal therapy
Hypertension, Pulmonary diagnosis
Hypertension, Pulmonary etiology
Hypertension, Pulmonary surgery
Liver Transplantation adverse effects
Pulmonary Arterial Hypertension
Subjects
Details
- Language :
- English
- ISSN :
- 1527-6473
- Volume :
- 28
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
- Publication Type :
- Academic Journal
- Accession number :
- 35106916
- Full Text :
- https://doi.org/10.1002/lt.26422